Cabaletta Bio, Inc.

Cabaletta Bio is a pharmaceutical company in the early stages of testing a new type of treatment for autoimmune diseases, which are conditions where the body's immune system mistakenly attacks itself. The company's main approach involves modifying a patient's own immune cells in the laboratory and putting them back into the body to fight the disease. Their experimental treatments are currently being tested in clinical trials for conditions including lupus, multiple sclerosis, myasthenia gravis, and various forms of muscle inflammation. The company was founded in 2017 and is based in Philadelph…